Population
29-year-old white man with no chronic medical problems, heterozygous for factor V Leiden, presenting with…
Design
Review
Follow-up
6 months
Authors
Loading...
May support clinical over thrombophilia-guided anticoagulation duration; leaves open validation in prospective cohorts.
Factor V Leiden increases the risk of venous thromboembolism, especially when combined with acquired risk factors, but acute management and duration of anticoagulation are generally guided by clinical factors rather than thrombophilia status.
Shaheen et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: